Position in EYPT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$65,076,427
-$25,851,808 QoQ
Shares Held
5,048,598
+1.4% QoQ
Ownership
6.02%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,057,408,835 across 166 Biotechnology names. EYPT ranks #24 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in EYPT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $65,076,427 | 5,048,598 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $90,928,235 | 4,976,915 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $59,407,627 | 4,171,884 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $40,473,566 | 4,301,123 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $22,492,246 | 4,149,861 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $30,824,872 | 4,137,567 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $32,056,261 | 4,012,048 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $31,751,946 | 3,649,649 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $70,055,528 | 3,389,237 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $107,245,443 | 4,640,651 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $33,178,033 | 4,152,445 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $44,061,870 | 5,064,583 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $16,987,730 | 5,778,140 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $20,210,781 | 5,774,509 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $44,374,126 | 5,609,877 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $42,893,489 | 5,450,253 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $64,635,909 | 5,319,828 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $60,553,298 | 4,947,165 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $33,076,590 | 3,174,337 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $25,142,089 | 2,796,673 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $29,344,589 | 2,888,247 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $9,303,771 | 1,413,947 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||